CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Head & Neck Cancer

ONCOLOGY. Vol. 17 No. 7
Pages: 1  2  3  
Previous Next
REVIEW ARTICLE 

The Multidisciplinary Management of Paragangliomas of the Head and Neck, Part 1

By Kenneth Hu, MD1, Mark S. Persky, MD2 | July 1, 2003
1Assistant Professor of Radiation Oncology, Albert Einstein College of Medicine, Beth Israel Medical Center 2Vice Chairman, Department of Otolaryngology-Head and Neck Surgery; Associate Director, Continuum Cancer Center, Codirector, Institute for Head and Neck Cancer, Beth Israel Medical Center, New York, New York; Professor of Clinical Otolaryngology–Head and Neck Surgery, Albert Einstein College of Medicine, Bronx, New York

Diagnostic Evaluation

Computed Tomography

FIGURE 2
Carotid Body Tumor

Computed tomography (CT) with thin sections (1-3 mm) is an excellent imaging technique by which to identify paragangliomas and document the extent of tumor with precise evaluation of bone invasion. The classic CT findings of paragangliomas include a homogeneous mass with intense enhancement following administration of intravenous contrast (Figure 2). Although this appearance is typical of these tumors, it may also be seen with other vascular tumors such as neurolemmoma and meningioma.[24]

FIGURE 3
Vascular Involvement

Tumor location, displacement of major vessels, and patterns of involvement or invasion of surrounding structures aid in the diagnosis of paraganglioma. For example, carotid body tumors typically display the common carotid bifurcation with posterolateral displacement of the internal carotid artery (Figure 3A).[27] By contrast, vagal paragangliomas will displace both the internal and external carotid arteries anteriorly (Figure 3B), and are associated with erosion and widening of the jugular foramen.

(MORE: Commentary (Chen): The Multidisciplinary Management of Paragangliomas of Head and Neck)

Jugular paragangliomas may be distinguished from tympanic tumors based on early involvement of the skull base, erosion of the caroticojugular spine,[27,42] and destruction of the ossicular chain, which is unusual with tympanic tumors.[43]

Magnetic Resonance Imaging

FIGURE 4
T2-Weighted MRI Study With Gadolinium Contrast

Although CT is the study of choice for the evaluation of bone involvement, magnetic resonance imaging (MRI) provides meticulous soft-tissue detail and defines skull-base, intracranial, dural, and neural involvement, especially with the use of gadolinium enhancement (Figure 4).[28] Augmented by its ability to produce images in multiple planes, MRI is superior to CT in defining the relationship of paragangliomas to adjacent vascular and skull-base structures.

MRI studies of paragangliomas demonstrate a background tumor matrix of intermediate signal intensity on T1-and proton density-weighted images and moderately high signal intensity on T2-weighted images, along with scattered areas of focal signal voids, reflecting high-flow blood vessels.[44] Intense homogeneous contrast enhancement is seen.[44] On T2-weighted images, the classic MRI "salt and pepper" appearance, originally described by Olsen et al[45] and present in most lesions greater than 1.5 cm, reflects signal voids intermixed with regions of focally high signal intensity, the latter of which are probably due to sites of slow flow within the image plane (Figure 4).[44]

These findings, however, are not specific for paragangliomas, and may be seen with other hypervascular lesions (eg, metastasic renal cell carcinoma and thyroid carcinoma). That said, the typically smooth contour, sig- nal characteristics, and location of paragangliomas, coupled with a detailed clinical history and physical findings should result in an accurate diagnosis.

It is also worth noting that MRI is more effective than CT in identifying small synchronous paragangliomas, especially those smaller than 5 mm. (CT is most effective in demonstrating lesions greater than 8 mm.[46])

Magnetic resonance angiography (MRA) provides excellent visualization of the major head and neck vasculature and can demonstrate vessel displacement, gross tumor involvement, and possible compromised blood flow. It may be useful in defining flow-related enhancement of lesions greater than 1.5 cm.[27] While three-dimensional time-of-flight angiography appears superior to other MRA techniques in identifying some tumor feeders, its sensitivity is not high enough to demonstrate detailed tumor vascular supply, which is best defined by digital subtraction superselective angiography.[47]

Radioisotope Imaging

Paragangliomas, like other neuroendocrine tumors, have been found to have a high density of somatostatin(Drug information on somatostatin) type 2 receptors on their cell surface. Octreotide(Drug information on octreotide) (Sandostatin) is a somatostatin analog, which, when coupled to the radioisotope indium-111, creates a scintigraphic image of tumors expressing somatostatin type 2 receptors. In a study of 21 patients with presumed head and neck paragangliomas who underwent indium-111/ octreotide scintigraphy, Telischi et al demonstrated an accuracy of 90%, a sensitivity of 94%, and a specificity of 75% in detecting tumors with this technique.[48]

Radioisotope scintigraphy provides a noninvasive imaging modality that is particularly useful in screening families with a history of paragangliomas. In addition, it is useful in detecting both synchronous and metachronous metastatic tumors.

Angiographic Evaluation

Angiography plays an important role in the evaluation of paragangliomas if surgery is being contemplated. It provides exquisite detail of the vascular anatomy, delineating the tumor blood supply (and possible anastomoses),[ 2] displacement of vessels, potential vessel compromise by tumor invasion, and adequacy of intracranial circulation if internal carotid artery sacrifice is necessary; this technique can also reveal previously undiagnosed synchronous paragangliomas.[ 49] Superselective angiography allows safe preoperative embolization of the tumor vasculature, hopefully avoiding proximal vessel occlusion and unexpected migration of embolization material into the cerebral or systemic circulation.

FIGURE 5
Contralateral Cerebral Blood Vessels

Our method of internal carotid balloon occlusion performed under local anesthesia with monitoring of mental functions for 20 minutes seems to be reliable in predicting a patient's tolerance to the interruption of carotid blood flow. More recently, we have relied on angiographic evidence of adequate contralateral cerebral blood without performing elective internal carotid balloon occlusion (Figure 5). 

In our study of 28 patients undergoing cerebral angiography, 26 (93%) demonstrated angiographic or balloon occlusion testing evidence of tolerance to possible carotid sacrifice.[ 28] With this preoperative information, surgical decisions about carotid bypass options can be made. Even with preparation for internal carotid artery grafting, a review of multiple series reports a 9.7% rate of strokes and a 2.4% incidence of mortality.[50]

TABLE 4
Commonly Used Staging Systems for Carotid Body Tumors and Jugulotympanic Paragangliomas

In our series, 4 of 47 patients with previously undiscovered paragangliomas were diagnosed on angiography (three carotid body tumors, one vagal paraganglioma). For these reasons, bilateral carotid angiography is an important part of the protocol in our evaluation of patients who are to undergo surgery.[28]

Biopsy

If a diagnosis of paraganglioma is suspected, an incisional biopsy is contraindicated due to the risk of hemorrhage and subsequent fibrosis at the operative site.[51] A fineneedle aspiration biopsy may be performed safely with minimal risk of bleeding.

Staging

The most commonly used staging systems for carotid body tumors and jugulotympanic paragangliomas are listed in Table 4.

Pages: 1  2  3  
Previous Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

The Multidisciplinary Management of Paragangliomas of the Head and Neck

The Multidisciplinary Management of Paragangliomas of the Head and Neck, Part 1

The Multidisciplinary Management of Paragangliomas of the Head and Neck, Part 2

Commentary (Barker/Garden): The Multidisciplinary Management of Paragangliomas of the Head and Neck

Commentary (Chen): The Multidisciplinary Management of Paragangliomas of Head and Neck






 
RELATED CONTENT

Parotid Gland Swelling in 45-Year-Old Patient
May 6, 2013
Status of HPV-Related Cancers and Vaccination Trends
February 21, 2013
A 53-Year-Old Man Presents With Painful Neck Swelling
August 30, 2012
Laryngeal Mass Discovered in 46-Year-Old Man
July 23, 2012
Locoregional Recurrence of an HPV-Positive Squamous Cell Carcinoma of the Head and Neck
ONCOLOGY,  October 12, 2011
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Head And Neck Cancer
Evidence on Head And Neck Cancer
Guidelines on Head And Neck Cancer
Patient Education on Head And Neck Cancer
Clinical Trials on Head And Neck Cancer
Practical Articles on Head And Neck Cancer
Research and Reviews on Head And Neck Cancer
All "Head And Neck Cancer" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy